The phainanoids are a recently
reported class of oxidatively modified triterpenoids isolated from Phyllanthus hainanensis, a lovely shrub
that is indigenous to the Hainan island of China. The architectural framework of
the phainanoids includes two rare and intricate spirocyclic motifs. One of
those, an eastern spiro-fused benzofurancyclobutanone, is unprecedented amongst
naturally occurring steroids. Plants in the genus Phyllanthus have long been used used in traditional Chinese and
Ayurvedic medicine for the treatment of infections, diabetes and hepatitis B.
The phainanoids were shown to exhibit potent immunosuppressive bioactivity in in vitro experiments that tested the
compounds’ abilities to inhibit the proliferation of T and B lymphocytes. New immunosuppressants
that are devoid of liver and renal toxicity offer tremendous therapeutic potential
as experimental candidates for the treatment of organ transplant and other
immunological-associated ailments such as rheumatoid arthritis. Phainanoid F
displayed impressive single-digit nanomolar potency against both T and B cells,
which far exceeds the immunosuppressive activity of the well-known transplant
drug, cyclosporin A.
While the western A-ring-annulated
cyclobutane system is quite unique, particularly amongst steroidal natural
products, the right-hand side of the phainanoids shares significant structural
homology with a known class of triterpenoids isolated from the Dichapetalaceae family of plants. The
dichapetalins are dammarane-type triterpenoids that contain a 2-phenylpyrano
system fused to the steroid A-ring. The C17 side chain of dichapetalin M (shown
below), comprised of a gamma-butyrolactone-spiroketal,
is very similar, in terms of atom connectivity, to the eastern substructure of the
six newly identified phainanoid natural products. This leads one to postulate
about a potential biogenic relationship between the two triterpenoid structural
classes. Indeed, in 2008, five highly complex dichapetalin-type triterpenoids,
coined the ‘acutissimatriterpenes,’ were isolated from a plant of the genus Phyllanthus (The phainanoids were also isolated
from a Phyllanthus species). The
dichapetalins were shown to exhibit cytotoxic activity against several cancer
cell lines, but no immunosuppressive activity was reported.
The eastern gamma-butyrolactone-spiroketal moiety of the phainanoids and
dichapetalins is likely derived from enzymatic oxidation of several positions
along the prototypical dammarane/cholestane C17 side chain. Oxidation of the
C20 substituent to an ester sets up a hypothetical
spiroketalization/lactonization event (shown below) that ultimately furnishes
this ornate spirocyclic structural motif.
The biosynthetic origin of the novel
western spiro-fused benzofurancyclobutanone is less obvious. However, given the
high degree of structural similarity between dichapetalin M and the phainanoid
class of triterpenoids, along with their common occurrence in Phyllanthus species of flowering plants,
it is tempting to propose dichapetalin M as a biogenetic precursor to the
phainanoids. Hypothetically speaking, oxidation of the ortho-position of the eastern phenyl ring of dichapetalin M could
produce the benzofuran moiety of the phainanoids. Subsequently, an allylic
radical adjacent to the benzofuran heteroatom could induce fragmentation of the
carbon-oxygen bond of the pyran system, resulting in a ring contraction to fashion
the unique phainanoid cyclobutane. It is noteworthy that all of the carbon
atoms of the phainanoid benzofurancyclobutanone are contained within the
2-phenylpyrano substructure of the dichapetalins. Installation of a single
oxygen atom, along with the aforementioned radical-induced ring contraction and
C-O bond fragmentation (shown below) seems like a plausible biosynthetic
pathway leading to the new triterpenoid class of immunosuppressive compounds.
Hopefully, future biosynthetic studies will be conducted to reveal the precise
nature of the biogenetic origin of the phainanoids.
This comment has been removed by the author.
ReplyDeleteThis comment has been removed by the author.
ReplyDeleteHi Nessa - sure, you can certainly use the images. No problem at all. Interesting synthetic targets, aren't they?
ReplyDeleteThis comment has been removed by the author.
DeleteNessa-
DeleteGlad we all have linear syntheses planned!
This comment has been removed by the author.
DeleteThis comment has been removed by the author.
ReplyDeleteThe maturing petroleum-based chemical industry, the pressures of environmental constraints and the explosive development of biotechnology have increased the interest in catalysis in enzymology. Biosynthesis
ReplyDeleteMaitake Extract , made in the USA. It is a great source of protein, carbohydrates, dietary fiber, vitamin D2 and vitamin K, potassium, sodium, calcium, and magnesium. It is a food supplement for daily use, Maitake mushrooms are effective in the treatment of cancer, hepatitis B and to improve immunity. Maitake is also used to treat hyperglycemia and control fat and cholesterol levels in the blood. Maitake also has antihypertensive and anti-inflammatory properties and is completely safe with minimal toxicity.
ReplyDelete